Gabapentin blood sugar
Pro Research Analysisby 
Searched over 200M research papers
Gabapentin and Blood Sugar Levels: Insights from Recent Research
Gabapentin-Induced Hypoglycemia
Mechanism and Case Reports
Gabapentin, a medication commonly used for epilepsy and neuropathic pain, has been associated with various side effects, including somnolence, sedation, and dizziness. Interestingly, while hyperglycemia is listed as a potential adverse reaction, there are case reports indicating that gabapentin can also induce hypoglycemia. One such case involved a 47-year-old woman who experienced severe hypoglycemia with a blood glucose level of 33 mg/dL after starting gabapentin a week prior. Her medical history and other medications did not suggest any other cause for the hypoglycemia, pointing towards gabapentin as the likely culprit .
Potential Mechanism of Hypoglycemia
The exact mechanism by which gabapentin induces hypoglycemia is not fully understood. However, it is hypothesized that gabapentin's binding to the alpha2delta subunit of voltage-gated calcium channels in the pancreas may play a role. This interaction could potentially affect insulin secretion and glucose regulation, leading to hypoglycemia .
Gabapentin and Fatalities: A Broader Perspective
Case of Acute Gabapentin Fatality
While gabapentin is generally considered safe with a favorable adverse effect profile, there are rare instances of severe outcomes. A case report detailed the fatality of a 47-year-old woman who ingested a significant amount of gabapentin, leading to elevated postmortem concentrations in various tissues. This case underscores the importance of monitoring gabapentin use, especially in scenarios of potential overdose .
Conclusion
Gabapentin, while effective for its intended uses, has complex interactions with blood sugar levels. Case reports suggest that it can induce hypoglycemia, potentially through its effects on pancreatic calcium channels. Although fatalities are rare, they highlight the need for careful monitoring of gabapentin, particularly in patients with other risk factors. Further research is essential to fully understand the mechanisms and to ensure safe use of this medication.
Sources and full results
Most relevant research papers on this topic